Xolair
Omalizumab · Genentech/Novartis
Xolair (omalizumab) is a biologic that targets IgE antibodies to reduce allergic reactions. Recently FDA-approved for food allergy reduction — the first treatment of its kind.
FDA-Approved Uses
Xolair is FDA-approved for the following conditions.
Dosing: 150-375mg injection every 2-4 weeks
Average Cost
What you can expect to pay for Xolair.
Need help affording Xolair?
Answer 9 questions. See every program you're eligible for. Free.
Medicaid Coverage by State
Xolair coverage status across all 51 states and territories.
| State | Medicaid | Medicare | Prior Auth |
|---|---|---|---|
| Alabama | Covered | Covered | No |
| Alaska | Covered | Covered | No |
| Arizona | Covered | Covered | No |
| Arkansas | Covered | Covered | No |
| California | Covered | Covered | No |
| Colorado | Covered | Covered | No |
| Connecticut | Covered | Covered | No |
| Delaware | Covered | Covered | No |
| District of Columbia | Covered | Covered | No |
| Florida | Covered | Covered | No |
| Georgia | Covered | Covered | No |
| Hawaii | Covered | Covered | No |
| Idaho | Covered | Covered | No |
| Illinois | Covered | Covered | No |
| Indiana | Covered | Covered | No |
| Iowa | Covered | Covered | No |
| Kansas | Covered | Covered | No |
| Kentucky | Covered | Covered | No |
| Louisiana | Covered | Covered | No |
| Maine | Covered | Covered | No |
| Maryland | Covered | Covered | No |
| Massachusetts | Covered | Covered | No |
| Michigan | Covered | Covered | No |
| Minnesota | Covered | Covered | No |
| Mississippi | Covered | Covered | No |
| Missouri | Covered | Covered | No |
| Montana | Covered | Covered | No |
| Nebraska | Covered | Covered | No |
| Nevada | Covered | Covered | No |
| New Hampshire | Covered | Covered | No |
| New Jersey | Covered | Covered | No |
| New Mexico | Covered | Covered | No |
| New York | Covered | Covered | No |
| North Carolina | Covered | Covered | No |
| North Dakota | Covered | Covered | No |
| Ohio | Covered | Covered | No |
| Oklahoma | Covered | Covered | No |
| Oregon | Covered | Covered | No |
| Pennsylvania | Covered | Covered | No |
| Rhode Island | Covered | Covered | No |
| South Carolina | Covered | Covered | No |
| South Dakota | Covered | Covered | No |
| Tennessee | Covered | Covered | No |
| Texas | Covered | Covered | No |
| Utah | Covered | Covered | No |
| Vermont | Covered | Covered | No |
| Virginia | Covered | Covered | No |
| Washington | Covered | Covered | No |
| West Virginia | Covered | Covered | No |
| Wisconsin | Covered | Covered | No |
| Wyoming | Covered | Covered | No |
Patient Assistance Programs
Genentech/Novartis offers savings programs that may reduce your cost to $0. Check eligibility below.
Check Eligibility at Genentech/Novartis ↗Xolair Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Injection site reactionscommon
- Headachecommon
- Joint paincommon
⚠️ Serious Side Effects
- Anaphylaxisrare
Seek immediate medical attention if you experience any serious side effects.
Frequently Asked Questions
How much does Xolair cost without insurance?
Xolair costs approximately $2,900 per month without insurance. With insurance, copays range from $5 to $500 per month.
Does Medicaid cover Xolair?
Medicaid coverage for Xolair varies by state. Many states cover it with prior authorization. See the coverage table below for your state.
What are the side effects of Xolair?
Common side effects include injection site reactions, headache, joint pain. Serious but rare side effects include anaphylaxis.
What is the generic name for Xolair?
The generic name for Xolair is Omalizumab. It is manufactured by Genentech/Novartis.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.